Report Categories
View AllRecent Articles
View All
What is the growth outlook for aTyr Pharma ATYR stock RangeBound 20260420
Gates Foundation Fiscal Framework and Payout Policy Update
What LM Funding LMFA disclosed about liquidity position Q4 2025 Earnings Fall Short
Nuveen NZF Stock Is It Approaching Breakout Zone Idled 20260420
Target Corporation TGT Unveils New Chapter Growth Plan Leveraging Fandom Partnerships and Wellness Category Expansion
What Cato Corp CATO is building for next year
Oracle Corporation ORCL Wedbush Reaffirms Outperform Rating Labels Recent Share Selloff as Unwarranted Overreaction
Global Jet Fuel Supply Disruptions and Aviation Sector Market Impact Analysis
DeFi Dev Co DFDV Stock Down 314 Support Test at 410 20260519
Commvault CVLT Gains 181 Support Holds at 9870 20260517
Kodiak AI KDKRW Gained 216 Can It Break 149 20260515
CapitaLand Investment Targets Larger Mandates Following Landmark 24 Billion Income Insurance Deal
Healthcare Technology Revolution Sensors 3D Printing and Personalized Medicine Reshape Industry
Amazon Reports RecordBreaking Thanksgiving Holiday Week
AnheuserBusch InBev Shares Decline After Sales Miss Expectations
Mixed Signals on Iran Nuclear Deal Keep Energy Markets on Edge
Cambodian Opposition Leader Receives Partial Pardon Implications for Investment Climate
Goldman Sachs Russian Crude Exports Remain Stable Despite Latest US Sanctions
KULR Q3 2025 Earnings EPS Misses Estimates Sharply Despite Strong Market Reaction
PENN Q1 2026 Earnings Steep EPS Miss Amid Operational Headwinds
Crocs Inc CROX Q1 2026 Earnings Strong EPS Beat Amidst Mixed Expectations
TG Therapeutics Q1 2026 Earnings EPS Disappoints as Stock Declines
ALKS Q1 2026 Earnings EPS Surpasses Estimates Amid Revenue Disclosure Gap Stock Slips
EFOI Q4 2024 Earnings Narrowed Loss Highlights Ongoing Restructuring Efforts
Clearfield Inc CLFD Surges Nearly 5 as Stock Breaks Above Key Support Level
NCR Voyix VYX Gains 24 as Shares Test Key Levels
HomesToLife Ltd HTLM Faces Heavy Selling Pressure Key Support at 163 Tested
NexPoint Residential Trust NXRT Slides Slightly While Holding Above Key Support Levels
TransCode Therapeutics RNAZ Surges 2 as Biotech Stock Tests Key Resistance at 655